TAO SHEN to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications TAO SHEN has written about Xenograft Model Antitumor Assays.
Connection Strength
0.356
-
CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-?B signaling pathway. Oncol Rep. 2017 Apr; 37(4):2095-2100.
Score: 0.111
-
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2025 01 09; 68(1):81-94.
Score: 0.048
-
Sodium Butyrate Inhibits the Malignant Proliferation of Colon Cancer Cells via the miR-183/DNAJB4 Axis. Biochem Genet. 2024 Oct; 62(5):4174-4190.
Score: 0.045
-
MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade. Nat Commun. 2022 01 11; 13(1):245.
Score: 0.039
-
LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Carcinogenesis. 2020 03 13; 41(1):111-121.
Score: 0.034
-
Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer. 2020 02; 8(1).
Score: 0.034
-
Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Biochem Pharmacol. 2016 09 15; 116:39-50.
Score: 0.027
-
The antitumor activity of the fungicide ciclopirox. Int J Cancer. 2010 Nov 15; 127(10):2467-77.
Score: 0.018